Table 1 Baseline characteristics, laboratory findings, and P2Y12 reaction units
Variables | Group A | Control C1 | p Value | Control C2 | p Value | p Value |
|---|---|---|---|---|---|---|
| Â | Â | Â | (A vs C1) | Â | (C1vs C2) | (A vs C2) |
Demographic characteristics | ||||||
 Men (%) | 17 (56.7%) | 25 (83.3%) | 0.048 | 67 (85.9%) | 0.973 | 0.002 |
 Age (years) | 70.0 ± 12.8 | 64.5 ± 12.0 | 0.091 | 62.9 ± 10.1 | 0.486 | 0.003 |
 Body mass index (kg/m2) | 25.1 ± 3.0 | 24.6 ± 2.0 | 0.474 | 25.2 ± 3.1 | 0.852 | 0.320 |
 Diabetes | 14 (46.7%) | 8 (26.7%) | 0.180 | 17 (21.8%) | 0.777 | 0.020 |
 Hypertension | 19 (63.3%) | 17 (56.7%) | 0.792 | 35 (44.9%) | 0.376 | 0.132 |
Medication at ER | ||||||
 Aspirin loading | 27 (90.0%) | 22 (73.3%) | 0.182 | 70 (89.7%) | 0.064 | 1.000 |
 Clopidogrel loading | 27 (90.0%) | 27 (90.0%) | 1.000 | 76 (97.4%) | 0.256 | 0.256 |
 Beta blocker | 26 (89.7%) | 23 (76.7%) | 0.326 | 71 (91.0%) | 0.095 | 1.000 |
 ACEI/ARB | 23 (79.3%) | 25 (83.3%) | 0.950 | 63 (80.8%) | 0.975 | 1.000 |
 CCB | 1 (3.4%) | 1 (3.3%) | 1.000 | 13 (16.7%) | 0.126 | 0.139 |
 Statin | 28 (96.6%) | 30 (100.0%) | 0.986 | 77 (98.7%) | 1.000 | 1.000 |
Major laboratory findings | ||||||
 Hematocrit (%) | 39.7 ± 5.8 | 41.3 ± 4.3 | 0.107 | 43.5 ± 4.4 | 0.022 | 0.000 |
 Platelet (×103/μl) | 213.6 ± 49.0 | 226.1 ± 63.2 | 0.396 | 220.9 ± 47.0 | 0.639 | 0.483 |
 Total cholesterol (mg/dl) | 162.9 ± 35.6 | 176.1 ± 51.1 | 0.261 | 189.9 ± 38.5 | 0.132 | 0.002 |
 Triglyceride (mg/dl) | 129.6 ± 85.7 | 133.5 ± 92.6 | 0.867 | 133.1 ± 81.1 | 0.982 | 0.848 |
 LDL cholesterol (mg/dl) | 98.4 ± 40.3 | 100.2 ± 36.5 | 0.861 | 116.9 ± 33.5 | 0.029 | 0.022 |
 Serum creatinine (mg/dl) | 0.9 ± 0.6 | 0.9 ± 0.2 | 0.819 | 0.8 ± 0.2 | 0.262 | 0.331 |
 Ejection fraction (%) | 57.1 ± 9.1 | 59.8 ± 6.2 | 0.201 | 59.6 ± 6.5 | 0.852 | 0.134 |
 P2Y12 reaction units | 277.2 ± 39.2 | 281.4 ± 38.4 | 0.672 | 171.1 ± 51.6 | 0.000 | 0.000 |